Tetragalacturonic acid hydroxymethylester

Tetragalacturonic acid hydroxymethylester
Clinical data

ATC code	B02BC03 (WHO)
Identifiers
IUPAC name Hydroxymethyl (2S,3R,4S,5R,6S)-6-[(2S,3R,4R,5R,6S)-6-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethoxycarbonyl)-6-[(2S,3R,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethoxycarbonyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethoxycarbonyl)tetrahydropyran-3-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylate
CAS Number	53008-15-4^Y
PubChem CID	72941563
ChemSpider	32698706
UNII	94C20R1E96
ChEBI	CHEBI:136025
Chemical and physical data
Formula	C₂₈H₄₂O₂₉
Molar mass	842.615 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C(O)OC(=O)[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@H](O[C@@H]2C(=O)OCO)O[C@@H]3[C@@H]([C@H]([C@H](O[C@@H]3C(=O)OCO)O[C@@H]4[C@@H]([C@H]([C@H](O[C@@H]4C(=O)OCO)O)O)O)O)O)O)O)O)O)O
InChI InChI=1S/C28H42O29/c29-1-47-22(43)17-6(34)5(33)11(39)26(55-17)53-15-8(36)13(41)28(57-19(15)24(45)49-3-31)54-16-9(37)12(40)27(56-20(16)25(46)50-4-32)52-14-7(35)10(38)21(42)51-18(14)23(44)48-2-30/h5-21,26-42H,1-4H2/t5-,6+,7+,8+,9+,10+,11+,12+,13+,14+,15+,16+,17-,18-,19-,20-,21-,26-,27-,28-/m0/s1 Key:PGQMFCVZFGJVNB-LRVJTQDXSA-N
(verify)

Tetragalacturonic acid hydroxymethylester is a local antihemorrhagic. It is derived from apple pectin. It is not used clinically, but research in the 1970s suggests that pectin and analogues may inhibit fibrinolysis in vitro.^[1]

References

^ Verstraete M (1979). "Haemostatic agents". Side Effects of Drugs Annual. 3: 281–289. doi:10.1016/S0378-6080(79)80041-0. ISBN 9780444900722.

Antihemorrhagics (B02)

Antihemorrhagics
(coagulation)

Systemic

Vitamin K	Phytomenadione (K₁) Menadione (K₃)
Coagulation factors	intrinsic: IX/Nonacog alfa VIII/(Damoctocog alfa pegol, Efanesoctocog alfa, Efmoroctocog alfa, Moroctocog alfa, Susoctocog alfa, Turoctocog alfa, Valoctocogene roxaparvovec) extrinsic: VII/Eptacog alfa common: X II/Thrombin I/Fibrinogen XIII/Catridecacog combinations: Prothrombin complex concentrate (II, VII, IX, X, protein C and S)
Other systemic	Batroxobin Carbazochrome Concizumab Etamsylate Fostamatinib thrombopoietin receptor agonist Romiplostim Avatrombopag Eltrombopag Lusutrombopag

Local

Antifibrinolytics

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

This page was last edited on 11 November 2023, at 21:25

From Wikipedia, the free encyclopedia

References